nominally significantP = 0.02
Although this difference in proportions was nominally significant (uncorrected P = 0.02), we did not see this effect in the equivalent analysis in the WGS cohort, where the proportion of HRCGS genes with more variants in ALS patients was indistinguishable from non-HRCGS genes (54% or 30 of 56 vs. 52% or 4,151 of 8,017, P = 0.089).